Stocks TradingCharts.com

stocks prices, charts & quotes

Free Stock Prices, Charts & Stock Price Quotes

Search
Symbol Search Browse Symbols My Charts Menu
QUICK QUOTE
QUICK CHART
F.A.Questions Suggestion Box Advertising Info Commodity Charts Forex Markets

Stocks & Financial News

Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts

Royal Bank of Canada to redeem NVCC Non-Cumulative 5-Year Rate Reset First Preferred Shares, Series BF

TORONTO, Sep. 8, 2025 (CNW Group via COMTEX) --
Royal Bank of Canada (TSX: RY) (NYSE: RY) today announced its intention to redeem all of its issued and outstanding Non-Viability Contingent Capital (NVCC) Non-Cumulative 5-Year Rate Reset First Preferred Shares, Series BF (Series BF shares) (TSX: RY.PR.M) on November 24, 2025, for cash at a redemption price of $25.00 per share to be paid on November 24, 2025.

There are 12,000,000 Series BF shares outstanding, representing $300 million of capital. The redemptions will be financed out of the general corporate funds of Royal Bank of Canada.

The final quarterly dividend of $0.1875 for each of the Series BF shares will be paid separately from the redemption price for each of the Series BF Shares and in the usual manner on November 24, 2025 to shareholders of record at the close of business on October 27, 2025. After such dividend payments, the holders of Series BF shares will cease to be entitled to dividends.

For further information, please contact:

Investor Contact:Asim Imran, Investor Relations, asim.imran@rbc.com, 416-955-7804

Media Contact:Tracy Tong, Financial Communications, tracy.tong@rbc.com, 437-655-1915

SOURCE Royal Bank of Canada

SOURCE: Royal Bank of Canada

SOURCE: RRYIR

SOURCE: RBC

comtex tracking

COMTEX_468639304/2197/2025-09-08T17:45:00

Do not sell my personal information

Copyright © 2025. All market data is provided by Barchart Solutions. Information is provided "as is" and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.